{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T23:39:47Z","timestamp":1790293187605,"version":"4.1.0"},"reference-count":104,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,7,27]],"date-time":"2020-07-27T00:00:00Z","timestamp":1595808000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81770568"],"award-info":[{"award-number":["81770568"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004829","name":"Department of Science and Technology of Sichuan Province","doi-asserted-by":"publisher","award":["2017JY0071"],"award-info":[{"award-number":["2017JY0071"]}],"id":[{"id":"10.13039\/501100004829","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine & Pharmacotherapy"],"published-print":{"date-parts":[[2020,10]]},"DOI":"10.1016\/j.biopha.2020.110558","type":"journal-article","created":{"date-parts":[[2020,8,8]],"date-time":"2020-08-08T23:27:08Z","timestamp":1596929228000},"page":"110558","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":26,"special_numbering":"C","title":["MicroRNAs in autoimmune liver diseases: from diagnosis to potential therapeutic targets"],"prefix":"10.1016","volume":"130","author":[{"given":"Chen","family":"Huang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xian","family":"Xing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyu","family":"Xiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoli","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruoting","family":"Men","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3296-6753","authenticated-orcid":false,"given":"Tinghong","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3821-9342","authenticated-orcid":false,"given":"Li","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopha.2020.110558_bib0005","article-title":"Diagnosis and management of autoimmune hepatitis in adults and children: 2019 practice guidance and guidelines from the American Association for the study of liver diseases","author":"Mack","year":"2019","journal-title":"Hepatology"},{"issue":"5","key":"10.1016\/j.biopha.2020.110558_bib0010","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1002\/hep.29307","article-title":"Regulatory T-cell conditioning endows activated effector T cells with suppressor function in autoimmune hepatitis\/autoimmune sclerosing cholangitis","volume":"66","author":"Liberal","year":"2017","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.biopha.2020.110558_bib0015","doi-asserted-by":"crossref","DOI":"10.1053\/j.gastro.2014.04.022","article-title":"Genome-wide association study identifies variants associated with autoimmune hepatitis type 1","volume":"147","author":"de Boer","year":"2014","journal-title":"Gastroenterology"},{"key":"10.1016\/j.biopha.2020.110558_bib0020","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1034\/j.1600-0528.2002.017401.x","article-title":"Genetic susceptibilities for immune expression and liver cell injury in autoimmune hepatitis","volume":"174","author":"Czaja","year":"2000","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.biopha.2020.110558_bib0025","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1186\/1824-7288-36-73","article-title":"HLA-DRB1 as a risk factor in children with autoimmune hepatitis and its relation to hepatitis A infection","volume":"36","author":"Elfaramawy","year":"2010","journal-title":"Ital. J. Pediatr."},{"issue":"3","key":"10.1016\/j.biopha.2020.110558_bib0030","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1053\/j.gastro.2005.12.020","article-title":"Polyclonal T-cell responses to cytochrome P450IID6 are associated with disease activity in autoimmune hepatitis type 2","volume":"130","author":"Ma","year":"2006","journal-title":"Gastroenterology"},{"issue":"6","key":"10.1016\/j.biopha.2020.110558_bib0035","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/j.dld.2014.02.003","article-title":"The association between Cytotoxic T lymphocyte associated antigen-4, Fas, tumour necrosis factor-alpha gene polymorphisms and autoimmune hepatitis: a meta-analysis","volume":"46","author":"Qin","year":"2014","journal-title":"Dig. Liver Dis."},{"issue":"8","key":"10.1016\/j.biopha.2020.110558_bib0040","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0071382","article-title":"Association of STAT4 polymorphisms with susceptibility to type-1 autoimmune hepatitis in the Japanese population","volume":"8","author":"Migita","year":"2013","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.biopha.2020.110558_bib0045","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.gendis.2017.12.006","article-title":"Cytotoxic T lymphocyte antigen-4 gene polymorphisms and susceptibility to type 1 autoimmune hepatitis in the Tunisian population","volume":"5","author":"Chaouali","year":"2018","journal-title":"Genes Dis."},{"issue":"1","key":"10.1016\/j.biopha.2020.110558_bib0050","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1002\/hep.510310110","article-title":"Cytotoxic T lymphocyte antigen-4 (CTLA-4) gene polymorphisms and susceptibility to type 1 autoimmune hepatitis","volume":"31","author":"Agarwal","year":"2000","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.biopha.2020.110558_bib0055","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1002\/hep.21316","article-title":"HLA class II alleles, genotypes, haplotypes, and amino acids in primary biliary cirrhosis: a large-scale study","volume":"44","author":"Donaldson","year":"2006","journal-title":"Hepatology"},{"issue":"6","key":"10.1016\/j.biopha.2020.110558_bib0060","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1038\/gene.2012.17","article-title":"Classical HLA-DRB1 and DPB1 alleles account for HLA associations with primary biliary cirrhosis","volume":"13","author":"Invernizzi","year":"2012","journal-title":"Genes Immun."},{"issue":"6","key":"10.1016\/j.biopha.2020.110558_bib0065","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1016\/S0168-8278(05)80617-8","article-title":"DNA typing of HLA class II genes; DRB1*0803 increases the susceptibility of Japanese to primary biliary cirrhosis","volume":"21","author":"Onishi","year":"1994","journal-title":"J. Hepatol."},{"issue":"2","key":"10.1016\/j.biopha.2020.110558_bib0070","first-page":"398","article-title":"Association of primary biliary cirrhosis with the allele HLA-DPB1*0301 in a German population","volume":"21","author":"Mella","year":"1995","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.biopha.2020.110558_bib0075","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/j.cld.2018.03.002","article-title":"The genetics and epigenetics of primary biliary cholangitis","volume":"22","author":"Tanaka","year":"2018","journal-title":"Clin. Liver Dis."},{"issue":"2","key":"10.1016\/j.biopha.2020.110558_bib0080","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/j.jhep.2012.03.031","article-title":"Extended analysis of a genome-wide association study in primary sclerosing cholangitis detects multiple novel risk loci","volume":"57","author":"Folseraas","year":"2012","journal-title":"J. Hepatol."},{"issue":"6","key":"10.1016\/j.biopha.2020.110558_bib0085","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1038\/ng.2616","article-title":"Dense genotyping of immune-related disease regions identifies nine new risk loci for primary sclerosing cholangitis","volume":"45","author":"Liu","year":"2013","journal-title":"Nat. Genet."},{"issue":"5","key":"10.1016\/j.biopha.2020.110558_bib0090","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1038\/ng.3528","article-title":"Analysis of five chronic inflammatory diseases identifies 27 new associations and highlights disease-specific patterns at shared loci","volume":"48","author":"Ellinghaus","year":"2016","journal-title":"Nat. Genet."},{"issue":"8","key":"10.1016\/j.biopha.2020.110558_bib0095","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0012403","article-title":"Mutational characterization of the bile acid receptor TGR5 in primary sclerosing cholangitis","volume":"5","author":"Hov","year":"2010","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.biopha.2020.110558_bib0100","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1002\/hep.21819","article-title":"A.B. Vigil Chacon, M. Crestani, Insights in the regulation of cholesterol 7alpha-hydroxylase gene reveal a target for modulating bile acid synthesis","volume":"46","author":"Mitro","year":"2007","journal-title":"Hepatology"},{"issue":"12","key":"10.1016\/j.biopha.2020.110558_bib0105","doi-asserted-by":"crossref","first-page":"586","DOI":"10.4254\/wjh.v9.i12.586","article-title":"Role of circulating microRNAs in liver diseases","volume":"9","author":"Loosen","year":"2017","journal-title":"World J. Hepatol."},{"key":"10.1016\/j.biopha.2020.110558_bib0110","doi-asserted-by":"crossref","first-page":"402","DOI":"10.3389\/fendo.2018.00402","article-title":"Overview of MicroRNA biogenesis, mechanisms of actions, and circulation","volume":"9","author":"O\u2019Brien","year":"2018","journal-title":"Front. Endocrinol."},{"key":"10.1016\/j.biopha.2020.110558_bib0115","article-title":"MicroRNAs in rheumatoid arthritis: from pathogenesis to clinical impact","volume":"18(11","author":"Evangelatos","year":"2019","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.biopha.2020.110558_bib0120","article-title":"Role of microRNA in the pathogenesis of systemic sclerosis tissue fibrosis and vasculopathy","volume":"18(11","author":"Henry","year":"2019","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.biopha.2020.110558_bib0125","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.jaut.2019.04.014","article-title":"MicroRNA-125a suppresses intestinal mucosal inflammation through targeting ETS-1 in patients with inflammatory bowel diseases","volume":"101","author":"Ge","year":"2019","journal-title":"J. Autoimmun."},{"issue":"17","key":"10.1016\/j.biopha.2020.110558_bib0130","doi-asserted-by":"crossref","first-page":"1974","DOI":"10.1182\/blood-2017-06-789321","article-title":"MicroRNA-17-92 is required for T-cell and B-cell pathogenicity in chronic graft-versus-host disease in mice","volume":"131","author":"Wu","year":"2018","journal-title":"Blood"},{"issue":"10070","key":"10.1016\/j.biopha.2020.110558_bib0135","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/S0140-6736(16)31715-9","article-title":"Safety, tolerability, and antiviral effect of RG-101 in patients with chronic hepatitis C: a phase 1B, double-blind, randomised controlled trial","volume":"389","author":"van der Ree","year":"2017","journal-title":"Lancet"},{"issue":"11","key":"10.1016\/j.biopha.2020.110558_bib0140","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0136908","article-title":"Circulating microRNA profiles in patients with Type-1 autoimmune hepatitis","volume":"10","author":"Migita","year":"2015","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.biopha.2020.110558_bib0145","doi-asserted-by":"crossref","first-page":"3350","DOI":"10.3892\/mmr.2016.5606","article-title":"Identification of microRNA profiles associated with refractory primary biliary cirrhosis","volume":"14","author":"Sakamoto","year":"2016","journal-title":"Mol. Med. Rep."},{"issue":"9","key":"10.1016\/j.biopha.2020.110558_bib0150","doi-asserted-by":"crossref","first-page":"10269","DOI":"10.1096\/fj.201802606R","article-title":"Secretin\/secretin receptor signaling mediates biliary damage and liver fibrosis in early-stage primary biliary cholangitis","volume":"33","author":"Kennedy","year":"2019","journal-title":"FASEB J."},{"issue":"3","key":"10.1016\/j.biopha.2020.110558_bib0155","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1002\/hep.29573","article-title":"MicroRNA 15a\/16-1 suppresses aryl hydrocarbon receptor-dependent interleukin-22 secretion in CD4(+) T cells and contributes to immune-mediated organ injury","volume":"67","author":"Lu","year":"2018","journal-title":"Hepatology"},{"issue":"6","key":"10.1016\/j.biopha.2020.110558_bib0160","doi-asserted-by":"crossref","first-page":"2562","DOI":"10.1002\/hep.30542","article-title":"Amelioration of ductular reaction by stem cell derived extracellular vesicles in MDR2 knockout mice via Lethal-7 microRNA","volume":"69","author":"McDaniel","year":"2019","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.biopha.2020.110558_bib0165","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1074\/jbc.M114.587030","article-title":"Post-translational regulation of the type III inositol 1,4,5-trisphosphate receptor by miRNA-506","volume":"290","author":"Ananthanarayanan","year":"2015","journal-title":"J. Biol. Chem."},{"issue":"2","key":"10.1016\/j.biopha.2020.110558_bib0170","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1002\/hep.25691","article-title":"Up-regulation of microRNA 506 leads to decreased Cl-\/HCO3- anion exchanger 2 expression in biliary epithelium of patients with primary biliary cirrhosis","volume":"56","author":"Banales","year":"2012","journal-title":"Hepatology"},{"issue":"12","key":"10.1016\/j.biopha.2020.110558_bib0175","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1139\/cjpp-2018-0467","article-title":"Inhibition of microRNA-155 attenuates concanavalin-A-induced autoimmune hepatitis by regulating Treg\/Th17 cell differentiation","volume":"96","author":"Xia","year":"2018","journal-title":"Can. J. Physiol. Pharmacol."},{"issue":"6","key":"10.1016\/j.biopha.2020.110558_bib0180","doi-asserted-by":"crossref","first-page":"2137","DOI":"10.1159\/000369658","article-title":"MicroRNA-223 acts as an important regulator to Kupffer cells activation at the early stage of Con A-induced acute liver failure via AIM2 signaling pathway","volume":"34","author":"Yang","year":"2014","journal-title":"Cell. Physiol. Biochem."},{"issue":"7014","key":"10.1016\/j.biopha.2020.110558_bib0185","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1038\/nature03049","article-title":"Processing of primary microRNAs by the Microprocessor complex","volume":"432","author":"Denli","year":"2004","journal-title":"Nature"},{"issue":"5957","key":"10.1016\/j.biopha.2020.110558_bib0190","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1126\/science.1178705","article-title":"A high-resolution structure of the pre-microRNA nuclear export machinery","volume":"326","author":"Okada","year":"2009","journal-title":"Science"},{"issue":"8","key":"10.1016\/j.biopha.2020.110558_bib0195","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1038\/nrm3838","article-title":"Regulation of microRNA biogenesis","volume":"15","author":"Ha","year":"2014","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"5","key":"10.1016\/j.biopha.2020.110558_bib0200","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1002\/wrna.1356","article-title":"Anatomy of RISC: how do small RNAs and chaperones activate Argonaute proteins?","volume":"7","author":"Nakanishi","year":"2016","journal-title":"Wiley Interdiscip. Rev. RNA"},{"issue":"3","key":"10.1016\/j.biopha.2020.110558_bib0205","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.molcel.2010.03.013","article-title":"Posttranscriptional regulation of microRNA biogenesis in animals","volume":"38","author":"Siomi","year":"2010","journal-title":"Mol. Cell"},{"issue":"4","key":"10.1016\/j.biopha.2020.110558_bib0210","first-page":"381","article-title":"Mechanisms of control of microRNA biogenesis","volume":"148","author":"Davis-Dusenbery","year":"2010","journal-title":"J. Biochem."},{"issue":"1","key":"10.1016\/j.biopha.2020.110558_bib0215","doi-asserted-by":"crossref","first-page":"60","DOI":"10.3748\/wjg.v21.i1.60","article-title":"Autoimmune hepatitis, one disease with many faces: etiopathogenetic, clinico-laboratory and histological characteristics","volume":"21","author":"Gatselis","year":"2015","journal-title":"World J. Gastroenterol."},{"issue":"2","key":"10.1016\/j.biopha.2020.110558_bib0220","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1111\/apt.12563","article-title":"Systematic review with meta-analysis: clinical manifestations and management of autoimmune hepatitis in the elderly","volume":"39","author":"Chen","year":"2014","journal-title":"Aliment. Pharmacol. Ther."},{"issue":"5","key":"10.1016\/j.biopha.2020.110558_bib0225","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1016\/S0168-8278(99)80297-9","article-title":"International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis","volume":"31","author":"Alvarez","year":"1999","journal-title":"J. Hepatol."},{"issue":"1","key":"10.1016\/j.biopha.2020.110558_bib0230","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1002\/hep.22322","article-title":"Simplified criteria for the diagnosis of autoimmune hepatitis","volume":"48","author":"Hennes","year":"2008","journal-title":"Hepatology"},{"issue":"4","key":"10.1016\/j.biopha.2020.110558_bib0235","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/j.jhep.2015.06.030","article-title":"EASL clinical practice guidelines: autoimmune hepatitis","volume":"63","year":"2015","journal-title":"J. Hepatol."},{"issue":"1","key":"10.1016\/j.biopha.2020.110558_bib0240","first-page":"1","article-title":"Hellenic association for the study of the liver clinical practice guidelines: autoimmune hepatitis","volume":"32","author":"Dalekos","year":"2019","journal-title":"Ann. Gastroenterol."},{"issue":"1","key":"10.1016\/j.biopha.2020.110558_bib0245","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1111\/liv.13458","article-title":"Autoimmune hepatitis: from current knowledge and clinical practice to future research agenda","volume":"38","author":"Sebode","year":"2018","journal-title":"Liver Int."},{"issue":"10201","key":"10.1016\/j.biopha.2020.110558_bib0250","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1016\/S0140-6736(19)31894-X","article-title":"Acute liver failure","volume":"394","author":"Stravitz","year":"2019","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.biopha.2020.110558_bib0255","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1111\/liv.14082","article-title":"Long-term clinical outcomes in patients with autoimmune hepatitis according to treatment response in Asian country","volume":"39","author":"Choi","year":"2019","journal-title":"Liver Int."},{"issue":"9","key":"10.1016\/j.biopha.2020.110558_bib0260","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1177\/2050640619872408","article-title":"Clinical management of autoimmune hepatitis","volume":"7","author":"Pape","year":"2019","journal-title":"United European Gastroenterol. J."},{"issue":"2","key":"10.1016\/j.biopha.2020.110558_bib0265","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1002\/hep.29833","article-title":"Expression of microRNA-155 in inflammatory cells modulates liver injury","volume":"68","author":"Blaya","year":"2018","journal-title":"Hepatology"},{"issue":"6","key":"10.1016\/j.biopha.2020.110558_bib0270","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.1159\/000362970","article-title":"MicroRNA expression profiles related to early stage murine concanavalin A-induced hepatitis","volume":"33","author":"Jia","year":"2014","journal-title":"Cell. Physiol. Biochem."},{"issue":"4","key":"10.1016\/j.biopha.2020.110558_bib0275","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1111\/jvh.12138","article-title":"Studying the association of microRNA-210 level with chronic hepatitis B progression","volume":"21","author":"Song","year":"2014","journal-title":"J. Viral Hepat."},{"key":"10.1016\/j.biopha.2020.110558_bib0280","doi-asserted-by":"crossref","first-page":"803","DOI":"10.3389\/fimmu.2019.00803","article-title":"The antidepressant mirtazapine inhibits hepatic innate immune networks to attenuate immune-mediated liver injury in mice","volume":"10","author":"Almishri","year":"2019","journal-title":"Front. Immunol."},{"issue":"5","key":"10.1016\/j.biopha.2020.110558_bib0285","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1177\/2050640618756124","article-title":"Receptor-interacting protein kinase 3 mediates macrophage\/monocyte activation in autoimmune hepatitis and regulates interleukin-6 production","volume":"6","author":"Zhang","year":"2018","journal-title":"United Eur. Gastroenterol. J."},{"issue":"1","key":"10.1016\/j.biopha.2020.110558_bib0290","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1002\/jcb.27338","article-title":"Silencing of microRNA-375 affects immune function in mice with liver failure by upregulating astrocyte elevated gene-1 through reducing apoptosis of Kupffer cells","volume":"120","author":"Ke","year":"2019","journal-title":"J. Cell. Biochem."},{"issue":"7","key":"10.1016\/j.biopha.2020.110558_bib0295","doi-asserted-by":"crossref","DOI":"10.1042\/BSR20190763","article-title":"Down-regulation of microRNA-138 improves immunologic function via negatively targeting p53 by regulating liver macrophage in mice with acute liver failure","volume":"39","author":"Wang","year":"2019","journal-title":"Biosci. Rep."},{"key":"10.1016\/j.biopha.2020.110558_bib0300","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.toxlet.2016.06.010","article-title":"MicroRNA-674-5p\/5-LO axis involved in autoimmune reaction of Concanavalin A-induced acute mouse liver injury","volume":"258","author":"Su","year":"2016","journal-title":"Toxicol. Lett."},{"key":"10.1016\/j.biopha.2020.110558_bib0305","first-page":"1256","article-title":"microRNA-143-3p attenuated development of hepatic fibrosis in autoimmune hepatitis through regulation of TAK1 phosphorylation","volume":"24(2","author":"Tu","year":"2019","journal-title":"J. Cell. Mol. Med."},{"issue":"5","key":"10.1016\/j.biopha.2020.110558_bib0310","doi-asserted-by":"crossref","first-page":"1920","DOI":"10.1002\/hep.29717","article-title":"Milder disease stage in patients with primary biliary cholangitis over a 44-year period: a changing natural history","volume":"67","author":"Murillo Perez","year":"2018","journal-title":"Hepatology"},{"key":"10.1016\/j.biopha.2020.110558_bib0315","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaut.2019.102328","article-title":"The challenges of primary biliary cholangitis: what is new and what needs to be done","volume":"105","author":"Terziroli Beretta-Piccoli","year":"2019","journal-title":"J. Autoimmun."},{"issue":"5","key":"10.1016\/j.biopha.2020.110558_bib0320","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1016\/j.jhep.2011.10.025","article-title":"Epidemiology of primary sclerosing cholangitis and primary biliary cirrhosis: a systematic review","volume":"56","author":"Boonstra","year":"2012","journal-title":"J. Hepatol."},{"issue":"7","key":"10.1016\/j.biopha.2020.110558_bib0325","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1056\/NEJMoa1509840","article-title":"A placebo-controlled trial of obeticholic acid in primary biliary cholangitis","volume":"375","author":"Nevens","year":"2016","journal-title":"New Engl. J. Med."},{"issue":"3","key":"10.1016\/j.biopha.2020.110558_bib0330","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1002\/hep.28932","article-title":"Long-term clinical impact and cost-effectiveness of obeticholic acid for the treatment of primary biliary cholangitis","volume":"65","author":"Samur","year":"2017","journal-title":"Hepatology"},{"issue":"5","key":"10.1016\/j.biopha.2020.110558_bib0335","doi-asserted-by":"crossref","first-page":"1890","DOI":"10.1002\/hep.29569","article-title":"A randomized trial of obeticholic acid monotherapy in patients with primary biliary cholangitis","volume":"67","author":"Kowdley","year":"2018","journal-title":"Hepatology"},{"key":"10.1016\/j.biopha.2020.110558_bib0340","first-page":"1170","article-title":"Long-term obeticholic acid therapy improves histological endpoints in patients with primary biliary cholangitis","volume":"18(5","author":"Bowlus","year":"2019","journal-title":"Clin. Gastroenterol. Hepatol."},{"issue":"6","key":"10.1016\/j.biopha.2020.110558_bib0345","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/S2468-1253(19)30094-9","article-title":"Long-term efficacy and safety of obeticholic acid for patients with primary biliary cholangitis: 3-year results of an international open-label extension study","volume":"4","author":"Trauner","year":"2019","journal-title":"Lancet Gastroenterol. Hepatol."},{"key":"10.1016\/j.biopha.2020.110558_bib0350","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.jhep.2020.02.033","article-title":"A randomized, placebo-controlled, phase II study of obeticholic acid for primary sclerosing cholangitis","volume":"73(1","author":"Kowdley","year":"2020","journal-title":"J. Hepatol."},{"issue":"5","key":"10.1016\/j.biopha.2020.110558_bib0355","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1038\/s41418-017-0019-x","article-title":"miRNA-21 ablation protects against liver injury and necroptosis in cholestasis","volume":"25","author":"Afonso","year":"2018","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.biopha.2020.110558_bib0360","first-page":"2118","article-title":"MicroRNA-210 promotes bile acid-induced cholestatic liver injury by targeting mixed-lineage leukemia-4 methyltransferase in mice","volume":"71(6","author":"Kim","year":"2019","journal-title":"Hepatology"},{"issue":"3\u20134","key":"10.1016\/j.biopha.2020.110558_bib0365","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.jaut.2009.02.022","article-title":"Primary biliary cirrhosis is associated with altered hepatic microRNA expression","volume":"32","author":"Padgett","year":"2009","journal-title":"J. Autoimmun."},{"issue":"3","key":"10.1016\/j.biopha.2020.110558_bib0370","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1111\/jgh.12040","article-title":"Analysis of altered microRNA expression profiles in peripheral blood mononuclear cells from patients with primary biliary cirrhosis","volume":"28","author":"Qin","year":"2013","journal-title":"J. Gastroenterol. Hepatol."},{"issue":"9","key":"10.1016\/j.biopha.2020.110558_bib0375","article-title":"MicroRNA-223 and microRNA-21 in peripheral blood B cells associated with progression of primary biliary cholangitis patients","volume":"12","author":"Wang","year":"2017","journal-title":"PLoS One"},{"issue":"10","key":"10.1016\/j.biopha.2020.110558_bib0380","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0111424","article-title":"Serum microRNAs as potential biomarkers of primary biliary cirrhosis","volume":"9","author":"Tan","year":"2014","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.biopha.2020.110558_bib0385","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0066086","article-title":"Distinct microRNAs expression profile in primary biliary cirrhosis and evaluation of miR 505-3p and miR197-3p as novel biomarkers","volume":"8","author":"Ninomiya","year":"2013","journal-title":"PLoS One"},{"issue":"6478","key":"10.1016\/j.biopha.2020.110558_bib0390","doi-asserted-by":"crossref","DOI":"10.1126\/science.aau6977","article-title":"The biology, function, and biomedical applications of exosomes","volume":"367","author":"Kalluri","year":"2020","journal-title":"Science"},{"issue":"2","key":"10.1016\/j.biopha.2020.110558_bib0395","doi-asserted-by":"crossref","DOI":"10.1016\/j.cmet.2018.09.011","article-title":"Lymphocyte-derived exosomal MicroRNAs promote pancreatic beta cell death and may contribute to type 1 diabetes development","volume":"29","author":"Guay","year":"2019","journal-title":"Cell Metab."},{"key":"10.1016\/j.biopha.2020.110558_bib0400","article-title":"Exosomes: Effectual players in rheumatoid arthritis","volume":"19(6","author":"Tavasolian","year":"2020","journal-title":"Autoimmun. Rev."},{"issue":"3","key":"10.1016\/j.biopha.2020.110558_bib0405","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1038\/cmi.2015.86","article-title":"The modulation of co-stimulatory molecules by circulating exosomes in primary biliary cirrhosis","volume":"14","author":"Tomiyama","year":"2017","journal-title":"Cell. Mol. Immunol."},{"issue":"6","key":"10.1016\/j.biopha.2020.110558_bib0410","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1016\/j.jhep.2018.08.020","article-title":"Primary biliary cholangitis: a tale of epigenetically-induced secretory failure?","volume":"69","author":"Rodrigues","year":"2018","journal-title":"J. Hepatol."},{"issue":"1","key":"10.1016\/j.biopha.2020.110558_bib0415","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.clinre.2015.10.001","article-title":"MicroRNAs in cholangiopathies: potential diagnostic and therapeutic tools","volume":"40","author":"Esparza-Baquer","year":"2016","journal-title":"Clin. Res. Hepatol. Gastroenterol."},{"issue":"4","key":"10.1016\/j.biopha.2020.110558_bib0420","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1002\/hep.29533","article-title":"MicroRNA-506 promotes primary biliary cholangitis-like features in cholangiocytes and immune activation","volume":"67","author":"Erice","year":"2018","journal-title":"Hepatology"},{"key":"10.1016\/j.biopha.2020.110558_bib0425","doi-asserted-by":"crossref","first-page":"44769","DOI":"10.1038\/srep44769","article-title":"Protection against oxidative stress mediated by the Nrf2\/Keap1 axis is impaired in Primary Biliary Cholangitis","volume":"7","author":"Wasik","year":"2017","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.biopha.2020.110558_bib0430","doi-asserted-by":"crossref","first-page":"131","DOI":"10.3892\/ijmm.2016.2610","article-title":"Altered expression of miR-92a correlates with Th17 cell frequency in patients with primary biliary cirrhosis","volume":"38","author":"Liang","year":"2016","journal-title":"Int. J. Mol. Med."},{"issue":"6","key":"10.1016\/j.biopha.2020.110558_bib0435","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1016\/j.jhep.2017.02.002","article-title":"miR-425 regulates inflammatory cytokine production in CD4(+) T cells via N-Ras upregulation in primary biliary cholangitis","volume":"66","author":"Nakagawa","year":"2017","journal-title":"J. Hepatol."},{"issue":"2","key":"10.1016\/j.biopha.2020.110558_bib0440","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1038\/s41575-019-0226-7","article-title":"Primary biliary cholangitis: pathogenesis and therapeutic opportunities","volume":"17","author":"Gulamhusein","year":"2020","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.biopha.2020.110558_bib0445","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.jaut.2012.12.013","article-title":"Overexpression of microRNA-21 is associated with elevated pro-inflammatory cytokines in dominant-negative TGF-beta receptor type II mouse","volume":"41","author":"Ando","year":"2013","journal-title":"J. Autoimmun."},{"issue":"9904","key":"10.1016\/j.biopha.2020.110558_bib0450","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1016\/S0140-6736(13)60096-3","article-title":"Primary sclerosing cholangitis","volume":"382","author":"Hirschfield","year":"2013","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.biopha.2020.110558_bib0455","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1016\/j.jhep.2017.07.022","article-title":"Primary sclerosing cholangitis - a comprehensive review","volume":"67","author":"Karlsen","year":"2017","journal-title":"J. Hepatol."},{"issue":"8","key":"10.1016\/j.biopha.2020.110558_bib0460","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1136\/gutjnl-2018-317993","article-title":"British Society of Gastroenterology and UK-PSC guidelines for the diagnosis and management of primary sclerosing cholangitis","volume":"68","author":"Chapman","year":"2019","journal-title":"Gut"},{"issue":"11","key":"10.1016\/j.biopha.2020.110558_bib0465","doi-asserted-by":"crossref","first-page":"15019","DOI":"10.1007\/s13277-016-5313-6","article-title":"Profiling of downregulated blood-circulating miR-150-5p as a novel tumor marker for cholangiocarcinoma","volume":"37","author":"Wu","year":"2016","journal-title":"Tumour Biol."},{"issue":"1","key":"10.1016\/j.biopha.2020.110558_bib0470","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1111\/cei.12776","article-title":"Serum microRNAs as novel biomarkers for primary sclerosing cholangitis and cholangiocarcinoma","volume":"185","author":"Bernuzzi","year":"2016","journal-title":"Clin. Exp. Immunol."},{"issue":"10","key":"10.1016\/j.biopha.2020.110558_bib0475","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0139305","article-title":"MicroRNAs in serum and bile of patients with primary sclerosing cholangitis and\/or cholangiocarcinoma","volume":"10","author":"Voigtlander","year":"2015","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.biopha.2020.110558_bib0480","doi-asserted-by":"crossref","first-page":"145","DOI":"10.15403\/jgld.2014.1121.272.cho","article-title":"Serum miRNA-122 is an independent biomarker of survival in patients with primary sclerosing cholangitis","volume":"27","author":"Friedrich","year":"2018","journal-title":"J. Gastrointestin. Liver Dis."},{"issue":"4","key":"10.1016\/j.biopha.2020.110558_bib0485","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1002\/hep.27262","article-title":"Activation of the developmental pathway neurogenin-3\/microRNA-7a regulates cholangiocyte proliferation in response to injury","volume":"60","author":"Marzioni","year":"2014","journal-title":"Hepatology"},{"issue":"10","key":"10.1016\/j.biopha.2020.110558_bib0490","doi-asserted-by":"crossref","first-page":"4305","DOI":"10.1096\/fj.201700097R","article-title":"Prolonged darkness reduces liver fibrosis in a mouse model of primary sclerosing cholangitis by miR-200b down-regulation","volume":"31","author":"Wu","year":"2017","journal-title":"FASEB J."},{"issue":"10","key":"10.1016\/j.biopha.2020.110558_bib0495","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1038\/s41419-018-1014-y","article-title":"MiR-873-5p acts as an epigenetic regulator in early stages of liver fibrosis and cirrhosis","volume":"9","author":"Fernandez-Ramos","year":"2018","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.biopha.2020.110558_bib0500","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.jss.2017.05.020","article-title":"Inhibition of microRNA-24 increases liver fibrosis by enhanced menin expression in Mdr2(-\/-) mice","volume":"217","author":"Hall","year":"2017","journal-title":"J. Surg. Res."},{"issue":"13","key":"10.1016\/j.biopha.2020.110558_bib0505","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.4155\/fmc.15.107","article-title":"miRNA therapeutics: a new class of drugs with potential therapeutic applications in the heart","volume":"7","author":"Bernardo","year":"2015","journal-title":"Future Med. Chem."},{"issue":"18","key":"10.1016\/j.biopha.2020.110558_bib0510","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1056\/NEJMoa1209026","article-title":"Treatment of HCV infection by targeting microRNA","volume":"368","author":"Janssen","year":"2013","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.biopha.2020.110558_bib0515","doi-asserted-by":"crossref","first-page":"4414","DOI":"10.1021\/acsnano.9b09998","article-title":"MicroRNA-125a-loaded polymeric nanoparticles alleviate systemic lupus erythematosus by restoring Effector\/Regulatory t cells balance","volume":"14(4","author":"Zhang","year":"2020","journal-title":"ACS Nano"},{"key":"10.1016\/j.biopha.2020.110558_bib0520","doi-asserted-by":"crossref","first-page":"5178","DOI":"10.1096\/fj.201902307RRR","article-title":"Exosomal miR-103-3p from LPS-activated THP-1 macrophage contributes to the activation of hepatic stellate cells","volume":"34(4","author":"Chen","year":"2020","journal-title":"FASEB J."}],"container-title":["Biomedicine & Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332220307514?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332220307514?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T18:03:46Z","timestamp":1766081026000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332220307514"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10]]},"references-count":104,"alternative-id":["S0753332220307514"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2020.110558","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2020,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"MicroRNAs in autoimmune liver diseases: from diagnosis to potential therapeutic targets","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2020.110558","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"110558"}}